William Blair restated their market perform rating on shares of athenahealth (NASDAQ:ATHN) in a research note issued to investors on Monday morning.

A number of other brokerages also recently weighed in on ATHN. BidaskClub downgraded athenahealth from a hold rating to a sell rating in a research note on Wednesday, July 25th. Cowen restated a hold rating and issued a $150.00 target price on shares of athenahealth in a research note on Wednesday, August 1st. Canaccord Genuity boosted their target price on athenahealth from $125.00 to $160.00 and gave the stock a hold rating in a research note on Tuesday, July 31st. Stifel Nicolaus restated a hold rating and issued a $140.00 target price (up previously from $134.00) on shares of athenahealth in a research note on Tuesday, July 31st. Finally, Cantor Fitzgerald reiterated a hold rating and issued a $145.00 price objective on shares of athenahealth in a research note on Tuesday, September 18th. One investment analyst has rated the stock with a sell rating, eighteen have issued a hold rating and three have assigned a buy rating to the company. athenahealth currently has an average rating of Hold and a consensus target price of $149.05.

Shares of NASDAQ ATHN opened at $131.63 on Monday. athenahealth has a twelve month low of $116.77 and a twelve month high of $163.94. The company has a market capitalization of $5.35 billion, a PE ratio of 83.84, a price-to-earnings-growth ratio of 2.33 and a beta of 0.80. The company has a current ratio of 2.74, a quick ratio of 2.62 and a debt-to-equity ratio of 0.22.

athenahealth (NASDAQ:ATHN) last announced its earnings results on Friday, November 9th. The health services provider reported $0.81 earnings per share for the quarter, topping analysts’ consensus estimates of $0.71 by $0.10. athenahealth had a return on equity of 15.35% and a net margin of 9.57%. The firm had revenue of $331.40 million for the quarter, compared to the consensus estimate of $336.98 million. During the same quarter in the previous year, the business earned $0.56 EPS. The company’s revenue was up 8.8% compared to the same quarter last year. On average, analysts forecast that athenahealth will post 3.21 EPS for the current fiscal year.

In related news, insider Daniel P. Haley sold 2,204 shares of the company’s stock in a transaction that occurred on Monday, October 1st. The stock was sold at an average price of $127.23, for a total value of $280,414.92. Following the transaction, the insider now owns 10,555 shares in the company, valued at $1,342,912.65. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. In the last quarter, insiders sold 2,654 shares of company stock worth $340,770. 2.90% of the stock is owned by company insiders.

Hedge funds have recently modified their holdings of the business. Kaizen Advisory LLC bought a new stake in athenahealth during the 3rd quarter valued at $886,000. Morgan Stanley raised its holdings in athenahealth by 0.6% during the 2nd quarter. Morgan Stanley now owns 4,565,845 shares of the health services provider’s stock valued at $726,608,000 after acquiring an additional 25,304 shares during the period. Point72 Asset Management L.P. bought a new stake in athenahealth during the 2nd quarter valued at $8,514,000. Oppenheimer & Co. Inc. raised its holdings in athenahealth by 37.5% during the 2nd quarter. Oppenheimer & Co. Inc. now owns 3,029 shares of the health services provider’s stock valued at $482,000 after acquiring an additional 826 shares during the period. Finally, Parkside Investments LLC bought a new stake in athenahealth during the 2nd quarter valued at $318,000.

athenahealth Company Profile

athenahealth, Inc, together with its subsidiaries, provides network-based medical record, revenue cycle, patient engagement, care coordination, and population health services for medical groups and health systems. It offers athenaCollector, a network-enabled billing and practice management solution; athenaClinicals, an electronic health record for managing patient's clinical documentation; athenaCommunicator, an engagement and communication solution that provides an automated communication service between patients and provider practices for interactions outside the exam room; and athenaCoordinator for order transmission and care coordination services.

Read More: What is the Dividend Aristocrat Index?

Analyst Recommendations for athenahealth (NASDAQ:ATHN)

Receive News & Ratings for athenahealth Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for athenahealth and related companies with MarketBeat.com's FREE daily email newsletter.